Rift Valley fever vaccines: an overview of the safety and efficacy of the live-attenuated MP-12 vaccine candidate
Introduction: Rift Valley fever (RVF) is a mosquito-borne zoonotic viral disease endemic to Africa and the Arabian Peninsula. High rates of abortion among infected ruminants and hemorrhagic fever in infected humans are major public health concerns. Commercially available veterinary RVF vaccines are...
Saved in:
Main Author: | Tetsuro Ikegami (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2017-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Attenuation and efficacy of live-attenuated Rift Valley fever virus vaccine candidates in non-human primates.
by: Darci R Smith, et al.
Published: (2018) -
Characterization of Rift Valley fever virus MP-12 strain encoding NSs of Punta Toro virus or sandfly fever Sicilian virus.
by: Olga A Lihoradova, et al.
Published: (2013) -
The Rift Valley fever (RVF) vaccine candidate 40Fp8 shows an extreme attenuation in IFNARKO mice following intranasal inoculation.
by: Belén Borrego, et al.
Published: (2024) -
Modelling Vaccination Strategies against Rift Valley Fever in Livestock in Kenya.
by: John M Gachohi, et al.
Published: (2016) -
In vitro and in vivo efficacy of a Rift Valley fever virus vaccine based on pseudovirus
by: Jian Ma, et al.
Published: (2019)